By John Black
Optical Coherence Tomography (OCT) is an imaging technology that can analyze tissue structure to a depth of 1-2mm and an accuracy of 1 to 10 microns. It can be used to detect disease conditions that modify tissue structure like arteriosclerosis, glaucoma, tooth cavities, and Alzheimer’s that affects the optic nerve. It supports any procedure that beneﬁts from real-time tissue structure information such as the accurate placement of a drug or device, or to assess treatment effects that change tissue structure such as cauterization or ablation.
By Shmuel Silverman
Most startup and mid-market CEOs are having a difﬁcult time articulating their patent portfolio strategy, and an even harder time connecting a patent to their company’s value proposition.
The main reason for this phenomenon is that patents are typically associated with technology and NOT with business strategy. Why is that?
We would like to welcome aboard Mike Moleschi, our new Director of Business Development.
Mike has an extensive background in system integration and automation, having worked in various capacities as an application engineer, analyst, and consultant for Schneider Electric, and Deloitt, among others. He graduated from the University of Alberta with a degree in Computer Engineering, and holds an MBA from the University of Oxford.
Thank you, Mr. Mark Shughart, Director of Hardware Engineering for Cala Health, for speaking at the September edition of our IoT and Wearable Devices Meetup on Neuro Science Retuning the Body – Wearables by Cala Health .
Cala Health is a bioelectronic medicine company whose wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.